US FDA paves the way for more OTC switches

18 July 2018 - Deborah Wilkes


Draft guidance from the US Food and Drug Administration (FDA) paves the way for companies switching medicines from prescription to non-prescription status to make use of new types of labelling and digital health technologies.

Click tags below for more information on topics:

FDA CHPA Digital Health

Annual Subscription Holder?

Sign in to continue reading.

Sign In

Back to Industry News

Share this page: